Ian K. Wright

1.1k total citations
18 papers, 943 citations indexed

About

Ian K. Wright is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Physiology. According to data from OpenAlex, Ian K. Wright has authored 18 papers receiving a total of 943 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Cellular and Molecular Neuroscience, 8 papers in Molecular Biology and 5 papers in Physiology. Recurrent topics in Ian K. Wright's work include Neurotransmitter Receptor Influence on Behavior (10 papers), Receptor Mechanisms and Signaling (5 papers) and Pain Mechanisms and Treatments (4 papers). Ian K. Wright is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (10 papers), Receptor Mechanisms and Signaling (5 papers) and Pain Mechanisms and Treatments (4 papers). Ian K. Wright collaborates with scholars based in United Kingdom, United States and France. Ian K. Wright's co-authors include C.A. Marsden, N. Upton, Mike Bickerdike, Dave Kendal, Hammad Ismail, V.G. Wilson, Colin T. Dourish, Carol Routledge, Michael P. Heaton and Emma J. Kidd and has published in prestigious journals such as PLoS ONE, Neurology and ACS Applied Materials & Interfaces.

In The Last Decade

Ian K. Wright

18 papers receiving 914 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ian K. Wright United Kingdom	15	611	329	290	237	133	18	943
Theo H. Hijzen Netherlands	21	531 0.9×	275 0.8×	293 1.0×	286 1.2×	283 2.1×	43	1.1k
Sharmin Maswood United States	14	453 0.7×	298 0.9×	183 0.6×	380 1.6×	173 1.3×	19	901
Donna Kocan United States	17	646 1.1×	237 0.7×	191 0.7×	318 1.3×	216 1.6×	20	1.1k
Dennis F. Fiorino Canada	11	512 0.8×	236 0.7×	208 0.7×	88 0.4×	173 1.3×	11	838
Cristina Orsini Italy	19	704 1.2×	246 0.7×	350 1.2×	263 1.1×	234 1.8×	36	1.1k
Sandra V. Vellucci United Kingdom	17	458 0.7×	278 0.8×	166 0.6×	268 1.1×	160 1.2×	25	891
Hideyasu Yokoo Japan	19	895 1.5×	325 1.0×	404 1.4×	422 1.8×	219 1.6×	40	1.3k
Allison T. Knoll United States	10	730 1.2×	190 0.6×	487 1.7×	218 0.9×	147 1.1×	14	1.1k
Hui Shen China	16	673 1.1×	318 1.0×	258 0.9×	338 1.4×	206 1.5×	42	1.2k
Jennifer E. Klebaur United States	9	565 0.9×	233 0.7×	220 0.8×	215 0.9×	145 1.1×	11	708

Countries citing papers authored by Ian K. Wright

Since Specialization

Citations

This map shows the geographic impact of Ian K. Wright's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ian K. Wright with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ian K. Wright more than expected).

Fields of papers citing papers by Ian K. Wright

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ian K. Wright. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ian K. Wright. The network helps show where Ian K. Wright may publish in the future.

Co-authorship network of co-authors of Ian K. Wright

This figure shows the co-authorship network connecting the top 25 collaborators of Ian K. Wright. A scholar is included among the top collaborators of Ian K. Wright based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ian K. Wright. Ian K. Wright is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Goadsby, Peter J., Uwe Reuter, Yngve Hallström, et al.. (2020). One-year sustained efficacy of erenumab in episodic migraine. Neurology. 95(5). e469–e479. 45 indexed citations

Wright, Ian K., Cathy Wyse, Pascale Blanc, et al.. (2014). Regulation of Pituitary MT1 Melatonin Receptor Expression by Gonadotrophin-Releasing Hormone (GnRH) and Early Growth Response Factor-1 (Egr-1): In Vivo and In Vitro Studies. PLoS ONE. 9(3). e90056–e90056. 15 indexed citations

Wright, Ian K., Andrew Higginbotham, S Baker, & T. D. Donnelly. (2010). Generation of Nanoparticles of Controlled Size Using Ultrasonic Piezoelectric Oscillators in Solution. ACS Applied Materials & Interfaces. 2(8). 2360–2364. 10 indexed citations

Graham, Simon P., Helen Everett, Helen L. Johns, et al.. (2009). Characterisation of virus-specific peripheral blood cell cytokine responses following vaccination or infection with classical swine fever viruses. Veterinary Microbiology. 142(1-2). 34–40. 25 indexed citations

Pinthong, Darawan, Ian K. Wright, Christian Hammer, et al.. (1995). Agmatine recognizes ?2-adrenoceptor binding sites but neither activates nor inhibits ?2-adrenoceptors. Naunyn-Schmiedeberg s Archives of Pharmacology. 351(1). 10–6. 77 indexed citations

Wright, Ian K., et al.. (1995). The relationship between density of α‐adrenoceptor binding sites and contractile responses in several porcine isolated blood vessels. British Journal of Pharmacology. 114(3). 678–688. 20 indexed citations

Wright, Ian K., Dave Kendal, & V.G. Wilson. (1995). ?2-Adrenoceptor mediated inhibition of forskolin-stimulated cyclic AMP accumulation in isolated porcine palmar lateral veins. Naunyn-Schmiedeberg s Archives of Pharmacology. 352(2). 113–20. 3 indexed citations

Wright, Ian K., et al.. (1995). Examination of the role of inhibition of cyclic AMP in α₂‐adrenoceptor mediated contractions of the porcine isolated palmar lateral vein. British Journal of Pharmacology. 114(1). 157–165. 19 indexed citations

Wright, Ian K., et al.. (1994). Potentiation by forskolin of both SNP‐ and ANP‐stimulated cyclic GMP accumulation in porcine isolated palmar lateral vein. British Journal of Pharmacology. 112(4). 1146–1150. 17 indexed citations

10.

Routledge, Carol, et al.. (1993). Neurochemical profile of the selective and silent 5-HT1A receptor antagonist WAY100135: an in vivo microdialysis study. European Journal of Pharmacology. 239(1-3). 195–202. 81 indexed citations

11.

Bickerdike, Mike, et al.. (1993). Social isolation attenuates rat forebrain 5-HT release induced by KCl stimulation and exposure to a novel environment. Behavioural Pharmacology. 4(3). 231???236–231???236. 100 indexed citations

12.

Wright, Ian K., Michael P. Heaton, N. Upton, & C.A. Marsden. (1992). Comparison of acute and chronic treatment of various serotonergic agents with those of diazepam and idazoxan in the rat elevated X-maze. Psychopharmacology. 107(2-3). 405–414. 58 indexed citations

13.

Wright, Ian K., N. Upton, & C.A. Marsden. (1992). Effect of established and putative anxiolytics on extracellular 5-HT and 5-HIAA in the ventral hippocampus of rats during behaviour on the elevated X-maze. Psychopharmacology. 109(3). 338–346. 115 indexed citations

14.

Wright, Ian K., Hammad Ismail, N. Upton, & C.A. Marsden. (1991). Effect of isolation rearing on 5-HT agonist-induced responses in the rat. Psychopharmacology. 105(2). 259–263. 90 indexed citations

15.

Kidd, Emma J., et al.. (1991). Inhibition of 5-hydroxytryptamine neuronal activity by the 5-HT agonist, DOI. European Journal of Pharmacology. 199(3). 349–355. 53 indexed citations

16.

Wright, Ian K., N. Upton, & C.A. Marsden. (1991). Resocialisation of isolation-reared rats does not alter their anxiogenic profile on the elevated X-maze model of anxiety. Physiology & Behavior. 50(6). 1129–1132. 144 indexed citations

17.

Wright, Ian K., et al.. (1990). Effects of a selective 5‐HT₂ agonist, DOI, on 5‐HT neuronal firing in the dorsal raphe nucleus and 5‐HT release and metabolism in the frontal cortex. British Journal of Pharmacology. 99(2). 221–222. 70 indexed citations

18.

Wright, Ian K. & C.A. Marsden. (1990). Inhibition of 5-HT release and metabolism in the frontal cortex by DOI is unaffected by 5-HT2 antagonists. European Journal of Pharmacology. 183(5). 1949–1949. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact